N05AX16 brexpiprazole
ATC group of level 5 – chemical substance · in plain English: medicines for psychosis, e.g. schizophrenia
This site has the patient leaflet or the SPC of 3 medicines in this group.
Active substance: Brexpiprazole – all medicines with this substance, also in combinations.
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N05 Psycholeptics 825 medicines
- N05A Antipsychotics 567 medicines
- N05AX Other antipsychotics 213 medicines
- N05AX16 brexpiprazole 3 medicines
- N05AX Other antipsychotics 213 medicines
- N05A Antipsychotics 567 medicines
- N05 Psycholeptics 825 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Rxulti SPC | – |
| Rxulti 0.25 mg film coated tablets SPC | – |
| Rxulti 4 mg film coated tablets SPC | – |
Other groups of the same level
- N05AX08 risperidone 41 medicines
- N05AX12 aripiprazole 115 medicines
- N05AX13 paliperidone 50 medicines
- N05AX15 cariprazine 4 medicines
Other names of the ATC group
- German: N05AX16 Brexpiprazol
- German: N05AX16 Brexpiprazol
- Italian: N05AX16 BREXPIPRAZOLO
- Turkish: N05AX16 brexpiprazol
- Portuguese (Brazil): N05AX16 Brexpiprazol
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N05AX16
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.